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Volume 56, Number 6 Abstracts 1825Homocysteine Upregulates Expression of NR2D-containing N-methyl-
D-aspartate Receptors in a Rat Carotid Endarterectomy Model
Mohammed Moursi, Hongju Deng, John Nyalala. University of Arkansas
for Medical Sciences, Little Rock, Ark
Introduction: We previously demonstrated that N-methyl-D-aspartate
(NMDA) receptor exists in vascular smooth muscle and endothelial cells
and that homocysteine may act via the NMDA receptor to increase
neointimal hyperplasia. In the current study, we first investigated the
expression profile of the constituent NMDA receptor subunits after a
vascular surgical procedure in an environment of hyperhomocysteinemia
in a rat model; and second, we evaluated the expression of NR2D-
containing NMDA receptor at transcriptional and protein level after
vascular injury in a rat model.
Methods: Rats were fed a homocysteine-supplemented diet or a con-
trol diet for 2 weeks before carotid endarterectomy (CEA) and continued on
preoperative diets. Animals were euthanized at 3, 8, or 14 days postopera-
tively and carotid arteries were processed for molecular studies (quantitative
real-time reverse transcriptase polymerase chain reaction, Western blot) and
histomorphometry.
Results: All five known NMDA receptor subunits (NR1, NR2A-2D)
messenger (m)RNAs were expressed in carotid arteries of homocysteinemic
rats at 2 weeks after CEA, but at different levels. Receptor subunit NR2D
mRNA rose sixfold vs NR2A, fourfold vs NR2B or NR1, and three times vs
NR2C (P .05). Protein bands corresponding to NR1 and NR2A-2D also
showed immunoreactivity at 2 weeks after injury. The receptor subunit
NR2D protein band was prominently expressed in the carotid artery com-
pared with other subunits. This robust NR2D receptor subunit protein
expression in the postinjury carotid artery is mimicking the high level of
mRNA expression observed using polymerase chain reaction. Homocysteine
supplementation for 8 or 14 days, but not 3 days after CEA, triggered
significant upregulation of both NR2D mRNA and protein vs control CEA
(all P  .0004). Furthermore, rats fed the control diet for 8 or 14 days, but
not 3 days after CEA, revealed a remarkable increase in NR2D mRNA and
protein expressions vs control non-CEA (intact) arteries (all P  .019).
Although damage to the carotid artery appears to upregulate the expression
of the NR2D receptor subunit, there was a quantitative difference in
response to vascular injury alone vs injury supplemented with homocysteine
at 3, 8, or 14 days postoperatively, with the latter being higher. Neointimal
hyperplasia, expressed as percentage luminal stenosis of the carotid artery
was significantly increased in CEA plus homocysteine vs CEA on control
diets at 2 weeks (P  .0001).
Conclusions: This preliminary study is the first to show that mRNA
and protein for NR2D-containing NMDA receptor were upregulated in the
carotid artery at 8 or 14 days after CEA in a time-dependent manner, with or
without homocysteine supplementation. CEA with homocysteine supple-
mentation for 2 weeks triggered a significant increase in luminal stenosis.
This morphologic and biochemical evidence represents the basis for our
assumption that the NR2D receptor subunit may be involved in homo-
cysteine-mediated hyperplastic response. We suggest that the NR2D
Fig 2.receptor subunit may constitute a useful therapeutic target to prevent/
attenuate neointimal proliferation after vascular injury.
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mtherectomy Offers no Benefits Over Balloon Angioplasty in Tibial
nterventions for Critical Limb Ischemia
evin E. Todd, Jr, Christian A. Maurer, Johnathan A. Higgins, Jung H.
im, Sadaf S. Ahanchi, JeanM. Panneton. Eastern VirginiaMedical School,
orfolk, Va
Introduction: Endovascular adjuncts, like atherectomy, have been
eveloped in order to improve outcomes for patients undergoing endovas-
ular treatment for peripheral arterial disease (PAD). The true impact of
therectomy on endovascular outcomes remains to be determined, and no
ata exist on the influence of atherectomy on tibial interventions. Our study
ompares the early and late outcomes of tibial intervention with angioplasty
s atherectomy.
Methods: We completed a retrospective review of all tibial interven-
ions between 2008 and 2010. Preprocedural, procedural, and postproce-
ural data were collected using paper and electronic systems. Factors affect-
ng patient outcomes were analyzed using single and multivariate analysis,
ox regression analysis, and Kaplan-Meier life-table curves. Primary out-
omes were primary, primary assisted, and secondary patency rates, as well as
imb salvage and survival.
Results: After review, 480 tibial interventions were completed for 421
imbs, 418 (87%) presented with critical limb ischemia (CLI) and 62 (13%)
ith claudication. A total of 192 isolated tibial interventions were com-
leted, and 288 multisegment interventions were completed. The CLI
ohort of 418 limbs was selected for analysis. These patients were a mean age
f 71 years, with a mean follow-up time of 16  15 months (range, 0-59
onths). Moat patients (60%) were men, with predominant risk factors of
ypertension (92%), tobacco use (64%), diabetes (72%), hyperlipidemia
65%), and chronic kidney disease (39%). Of the 418 limbs, 339 underwent
ercutaneous transluminal angioplasty (PTA): 333 PTA alone and six
TAstent. The remaining 79 limbs received atherectomy (33 laser, 13
irectional, 33 orbital) alone or in conjunction with PTA (11 atherectomy
nly, 68 atherectomyPTA). The groups did not differ significantly in age,
ex, risk factors, occlusion vs stenosis, or technical success. The atherectomy
roup had significantly more TransAtlantic Inter-Society Consensus
TASC) B lesions (54% vs 38%, P  .013), and the PTA group had
ignificantly more TASC D lesions (25% vs 13%, P  .049). TASC A and C
esions did not differ significantly between the two groups. No significant
ifferences existed with respect to the early (30-day) outcomes of loss of
atency (11% vs 13%, P .70), complications (9% vs 13%, P .41), or major
mputation (17% vs 13%, P  .34). Furthermore, there was no difference
etween treatment groups in symptomatic relief at first follow-up (61% vs
5%, P  .53) or Rutherford score improvement (70% vs 69%, P  .81).
aplan-Meier analysis revealed no difference in primary outcomes of PTA vs
therectomy at the 12-month and 36-month assessments: primary patency
69% and 55% vs 61% and 46%, P .15), primary assisted patency (83% and
1% vs 85% and 67%, P .80), secondary patency (94% and 89% vs 95% and
9%, P  .89), limb salvage (79% and 70% vs 81% and 77%, P  .49), or
urvival (77% and 56% vs 80% and 50%).
Conclusions: The adjunctive use of atherectomy offered no improve-
ent over PTA in early or late outcomes in patients with CLI who under-
ent endovascular tibial interventions. Considering the additional cost and
ncreased procedural time, these findings put into question the routine use of
djunctive atherectomy.
rospective, Multicenter Analysis of Perioperative Patency for Tibial
ypass: Comparison Among Different Conduit Configurations
ao-Ngoc H. Nguyen, Richard F. Neville, Richard Amdur, Mustafa Abugi-
eiri, Anton Sidawy. George Washington University, Washington, DC
Introduction: Despite advances in endovascular techniques, tibial
ypass may still be required for revascularization to obtain healing and limb
alvage. Perioperative (30-day) graft patency is an important outcome
arameter reflecting technical considerations and acute graft thrombosis.
oth are important prerequisites for long-term patency. In this analysis, the
0-day patency of the great saphenous vein (GSV) is compared with alter-
ative conduit configurations for tibial bypasses.
Methods: The study cohort consisted of all primary tibial bypasses
ntered in a prospective, multicenter database (American College of Sur-
eons-National Surgical Quality Improvement Program) from 2006 to
010 with exclusion of reoperative cases. The bypasses were divided into six
roups: (1) GSV, (2) prosthetic conduit, (3) prosthetic conduit with a distal
nastomotic venous adjunct, such as a cuff or patch, (4) composite graft of
xpanded polytetrafluoroethylene and a vein segment, (5) spliced autoge-
ous vein, and (6) arm vein. Thirty-day graft failure, patient demographics,
nd operative details were compared among groups. Univariate associations
etween patient factors and conduit were tested, and those variables that had
 .20 were used in a multivariate model to predict patency.
Results:A total of 5375 tibial bypasses were analyzed by conduit: GSV,
983 (74%); prosthetic, 889 (17%); spliced vein, 160 (3%); prosthetic with
djunct, 112 (2%); arm vein, 93 (2%); and composite, 91 (2%). There was no
ifference among groups in terms of diabetes, renal failure, tobacco use, or
est pain as an indication for bypass. There was no difference in perioperative
ortality based on conduit. After adjusting for gender, age, weight, race,
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December 20121826 AbstractsTable. Patient preoperative variables and perioperative outcomes
Variable
GSV Spliced vein Arm vein Prosthetic Prosthetic/venous adjunct Composite
(n  3983) (n  160) (n  93) (n  889) (n  112) (n  91)
Female, No. (%) 1280 (32.2) 49 (31.2) 23 (24.7) 315 (35.2) 33 (29.7) 39 (42.9)
Age, years 69.5  12.3 71.3  11.2 67.5  10.9 70.6  11.4 70.2  12.0 70.9  11.3
CABG, No. (%) 874 (21.9) 55 (34.4) 43 (46.2) 311 (34.6) 41 (36.6) 22 (24.2)
Transfusion 0.5  1.1 1.2  1.7 0.4  0.8 0.5  1.2 0.7  1.1 0.6  1.2
OR time, hours 4.4  1.8 6.1  1.9 5.1  2.3 3.7  1.6 4.4  1.8 4.7  2.0
Mortality 127 (3.2) 4 (2.5) 2 (2.2) 40 (4.5) 1 (0.9) 4 (4.4)
30-day graft failure, No. (%) 300 (7.5) 9 (5.6) 4 (4.3) 94 (10.5) 11 (9.8) 14 (15.4)
P vs GSV . . . .37 .24 .004 .37 .006a
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tand previous cardiac surgery (coronary artery bypass grafting), the bypass
conduit had a significant independent association with 30-day graft patency
(P  .006). The GSV failure rate was 7.5%. Composite grafts had a
significantly higher 30-day failure rate (15.4%, P  .006). There was no
significant difference in 30-day patency of spliced vein (5.6%, P  .37) or
arm vein (4.3%, P  .24) conduits compared with GSV. However, spliced
vein and arm vein involved longer operating room time, and spliced vein
increased transfusion requirements. Prosthetic grafts had significantly lower
30-day patency compared with GSV (10.5%, P  .004). The addition of
adjuvant venous tissue at the distal anastomosis of prosthetic bypasses did
not significantly improve their 30-day patency (prosthetic/venous adjunct
graft failure rate, 9.8% vs prosthetic graft failure rate, 10.5%).
Conclusions: Venous conduits (GSV, spliced vein, arm vein) deliver
the best perioperative patency for tibial bypass, and GSV remains the most
commonly used graft for tibial revascularization. Prosthetic grafts had a
higher perioperative bypass failure rate. Composite grafts should be aban-
doned because their patency is not better than pure prosthetic conduits. The
addition of a distal venous adjunct did not seem to improve acute prosthetic
graft patency, which may reflect lack of effect on thrombogenicity rather
than the myointimal hyperplastic response that impacts long term failure of
tibial bypass.
Spliced Arm Vein Grafts for Critical Lower Limb Ischemia
Luigi Pascarella, Leila Mureebe, Mitchell W. Cox, Richard L. McCann. Duke
University Medical Center, Durham, NC
Introduction: Many patients with critical limb ischemia do not have
adequate ipsilateral saphenous vein for constructing a bypass due to prior
harvesting for limb or coronary artery bypass grafting or to intrinsic vein
disease. Prosthetic conduits or frozen or tanned homografts have poor
long-term patency, especially for distal bypass. This study reviews our
experience with an alternate conduit using spliced arm veins for bypass of
critical lower limb ischemia.S
mFig.Methods: A retrospective record review was conducted of all patients
t a single institution over an 11-year period. Statistical analysis was con-
ucted by Kaplan-Meier survival analysis and Cox proportional hazards
odel. Statistical significance was set at P  .05.
Results: Since 2001, 33 patients (22 men, 11 women; mean age, 65
ears) with critical limb ischemia underwent 34 bypass operations using a
onduit containing at least one arm vein segment and one or more splices.
ll had rest pain or tissue loss, and 70% had undergone a mean of 1.3 prior
ypass attempts (range, 0-4). Twenty percent of patients had undergone
ttempts at percutaneous revascularization. Conduits consisted of cephalic
ein (n  16), basilic vein (n  32), and residual saphenous vein (n  24)
egments. Six grafts (18%) had two splices. Eighty-five percent of bypasses
ere to tibial vessels. Patency at 1 year was 100% (20 of 20) and at 2 years was
5% (12 of 14, Fig). One patient with a patent stent graft required ampu-
ation, and one patient underwent amputation after graft thrombosis. There
as no statistical impact on amputation or patency based on source of vein,
nflow artery, outflow artery, number of splices or patient age.
Conclusions: Spliced arm vein grafts provide durable lower extremity
evascularization and limb salvage when intact saphenous vein is not avail-
ble. Spliced arm grafts are superior to prosthetic or frozen homografts for
epeat bypass after failure of an initial autogenous graft.
omparison of Long-term Outcomes Following Endovascular Repair
f Abdominal Aortic Aneurysms Based on Size Threshold
harles J. Keith, Jr, Marc A. Passman, Michael J. Gaffud, Zdenek Novak,
arjan U. Mujib, Thomas C. Matthews, Mark A. Patterson, William D.
ordan, Jr. University of Alabama at Birmingham, Birmingham, Ala
Introduction: Size threshold for operative repair of abdominal aortic
neurysms (AAA) has been determined based on risks and outcomes of open
epair vs surveillance. The influence of endovascular repair (EVAR) on this
hreshold is less established. The purpose of this study is to determine
hether long-term outcomes of EVAR are affected bymaximum diameter at
ime of treatment.
Methods:All patients who underwent EVARwithmodular stent grafts
etween January 2000 and December 2011 at a single academic institution
ere identified from a prospectively maintained database. Patients were
tratified based onmaximum aortic diameter at time of repair: small (4.0-4.9
m), medium (5.0-5.9 cm), and large (6.0 cm). Comparisons of demograph-
cs, indications for repair, and perioperative complications were made among
he groups. Long-term follow-up was reviewed for expansion of the native
neurysm sac 5 mm, secondary intervention involving the native aneurysm or
tent graft, and all-cause mortality. Statistical analyses were made using analysis
f variance, 2, and Kaplan-Meier plots.
Results: During the study period, 740 patients underwent EVAR with
odular stent grafts: 157 small (21.2%), 374 medium (50.5%), and 209
arge (28.2%). Preoperative patient characteristics were similar among the
roups with exception to mean age (69.3 8.09, 71.7 8.55, and 73.6
.77 years for small, medium, and large, respectively; P  .001), history of
oronary artery disease (42% small, 57% medium, 51.2% large; P  .01),
rior coronary angioplasty (14.6% small, 18.2% medium, 9.6% large; P 
02), congestive heart failure (5.7% small, 15.2% medium, 19.6% large; P 
01), prior vascular surgery (7% small, 15.8% medium, 10% large; P .016),
nd chronic obstructive pulmonary disease (21% small, 27% medium, 33%
arge; P  .038). Clinical classification differed significantly as a larger
ercentage of small AAAs were symptomatic (19.7% small, 7.5% medium,
.1% large; P  .001). No difference in perioperative complication rates
P .399) or all-type endoleak at any surveillance visit (40.8% small, 41.7%
edium, 44.5% large; P  .73) was observed among the groups. However,
he small AAA group developed fewer type I endoleaks (5.1% vs 6.95%
edium and 14.8% large; P  .001). Aneurysm sac expansion of 5 mm was
bserved in 2.6% of small, 5.6% of medium, and 7.2% of large AAAs during
he follow-up period but did not achieve a significant difference (P .148).
econdary intervention rates differed significantly as 5.1% of small, 7.5% of
edium, and 12.9% large AAAs required secondary intervention (P .018).
